2001 | 2007 | 2014 | |||||||
---|---|---|---|---|---|---|---|---|---|
N (%) or Mean (Std) | % with tobacco diagnosis | ORs | N (%) or Mean (Std) | % with tobacco diagnosis | ORs | N (%) or Mean (Std) | % with tobacco diagnosis | ORs | |
All | 1,190,827 | 3.61% | 1,234,434 | 5.49% | 1,362,211 | 12.97% | |||
Age | |||||||||
66–69 | 243,110 (20.42%) | 4.62% | Reference | 225,138 (18.24%) | 7.14% | Reference | 326,808 (23.99) | 13.01% | Reference |
70–74 | 312,072 (26.21%) | 4.39% | 0.92 (0.89–0.94) | 315,571 (25.56%) | 6.54% | 0.88 (0.86–0.90) | 328,549 (24.12%) | 14.22% | 1.01 (0.99–1.02) |
75–79 | 276,067 (23.18%) | 3.68% | 0.74 (0.71–0.76) | 278,436 (22.56%) | 5.67% | 0.72 (0.70–0.74) | 259,600 (19.06%) | 13.93% | 0.91 (0.90–0.93) |
80–84 | 190,697 (16.01%) | 2.78% | 0.54 (0.52–0.56) | 217,819 (17.65%) | 4.51% | 0.55 (0.54–0.57) | 205,506 (15.09%) | 13.15% | 0.81 (0.80–0.83) |
85+ | 168,881 (14.18%) | 1.52% | 0.30 (0.28–0.31) | 197,470 (16.00%) | 2.74% | 0.33 (0.32–0.34) | 241,748 (17.75%) | 10.01% | 0.58 (0.57–0.60) |
Gender | |||||||||
Female | 715,118 (60.05%) | 2.87% | Reference | 724,263 (58.67%) | 4.42% | Reference | 815,915 (59.90%) | 10.70% | Reference |
Male | 475,709 (39.95%) | 4.71% | 1.54 (1.51–1.57) | 510,171 (41.33%) | 7.00% | 1.52 (1.50–1.55) | 546,296 (40.10%) | 16.35% | 1.66 (1.64–1.68) |
Race/Ethnicity | |||||||||
White | 1,054,364 (88.54%) | 3.71% | Reference | 1,040,394 (84.28%) | 5.70% | Reference | 1,136,026 (83.40%) | 13.42% | Reference |
Black | 88,485 (7.43%) | 3.30% | 0.84 (0.81–0.88) | 92,454 (7.49%) | 5.55% | 0.93 (0.90–0.96) | 101,084 (7.42%) | 13.86% | 0.96 (0.94–0.98) |
Hispanic | 21,744 (1.83%) | 1.89% | 0.41 (0.37–0.46) | 64,186 (5.20%) | 3.21% | 0.49 (0.46–0.52) | 69,191 (5.08%) | 8.46% | 0.53 (0.52–0.55) |
Others | 26,234 (2.20%) | 1.93% | 0.46 (0.42–0.50) | 37,400 (3.03%) | 3.31% | 0.54 (0.50–0.57) | 55,910 (4.10%) | 7.64% | 0.52 (0.50–0.54) |
Medicaid eligible | |||||||||
Yes | 151,482 (12.72%) | 4.40% | Reference | 167,008 (13.53%) | 6.51% | Reference | 174,648 (12.82%) | 16.00% | Reference |
No | 1,039,345 (87.28%) | 3.49% | 0.73 (0.71–0.75) | 1,067,426 (86.47%) | 5.33% | 0.78 (0.76–0.80) | 1,187,563 (87.18%) | 12.52% | 0.80 (0.79–0.81) |
Elixhauser Comorbidity | |||||||||
0–1 | 770,969 (64.74%) | 3.36% | Reference | 699,085 (56.63%) | 4.86% | Reference | 691,542 (50.76%) | 9.60% | Reference |
2–3 | 296,602 (24.91%) | 3.82% | 1.06 (1.04–1.09) | 354,357 (28.71%) | 6.00% | 1.16 (1.14–1.19) | 412,131 (30.25%) | 13.97% | 1.44 (1.42–1.46) |
4+ | 123,256 (10.35%) | 4.63% | 1.07 (1.03–1.10) | 180,992 (14.66%) | 6.92% | 1.09 (1.06–1.120 | 258,556 (18.98%) | 20.37% | 1.90 (1.87–1.93) |
COPD or Emphysema | |||||||||
Yes | 190,128 (15.97%) | 8.85% | Reference | 204,062 (16.53%) | 13.35% | Reference | 216,620 (15.90%) | 30.11% | Reference |
No | 1,000,699 (84.03%) | 2.61% | 0.28 (0.27–0.29) | 1,030,372 (83.47%) | 3.93% | 0.27 (0.26–0.28) | 1,145,591 (84.10%) | 9.73% | 0.28 (0.28–0.29) |